⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 15, 2013Pharmacogenetics and GenomicsOpen Access

PharmGKB summary

Katrin Sangkuhl Julia Stingl Miia Turpeinen Russ B. Altman Teri E. Klein

View Full Paper

Ask AI

Bookmark

Share

Abstract

Sangkuhl, Katrin; Stingl, Julia C.; Turpeinen, Miia; Altman, Russ B.; Klein, Teri E. Author Information

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Sangkuhl et al. (2013) studied this question.

synapsesocial.com/papers/6a7c6e4b5d6f11e376eadd44 https://doi.org/10.1097/fpc.0000000000000003

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Metabolic disposition of14C-venlafaxine in mouse, rat, dog, rhesus monkey and manEarly-Phase Clinical Trial · 1993 · 123 citations
2Introduction of a Composite Parameter to the Pharmacokinetics of Venlafaxine and its Active O‐Desmethyl MetaboliteOriginal Research · 1992 · 202 citations
3Venlafaxine oxidation<i>in vitro</i>is catalysed by CYP2D6Original Research · 1996 · 227 citations
4Depressive effect of an antidepressant: therapeutic failure of venlafaxine in a case lacking CYP2D6 activityEarly-Phase Clinical Trial · 2009 · 33 citations
5Cyp2d6 genotype: impact on adverse effects and nonresponse during treatment with antidepressants—a pilot studyPilot Study · 2004 · 198 citations

More related papers

Venlafaxine Serum Levels and CYP2D6 Genotype2000
Venlafaxine Metabolism as a Marker of Cytochrome P450 Enzyme 2D6 Metabolizer Status2009
Effect of the <i>CYP2D6*10</i> genotype on venlafaxine pharmacokinetics in healthy adult volunteers1999

More from Pharmacogenetics and Genomics

Distribution of the J1 haplotype variant rs2267439 across CYP2D6 diplotypes and its impact on risperidone metabolismWed,
Genetic variation in SLCO1B1 is associated with methotrexate intolerance symptoms in juvenile idiopathic arthritis patientsTue,